Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations

BACKGROUND: The efficacy of immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC) patients harboring neurotrophin receptor kinase (NTRK) family mutations remains obscure. METHODS: The Zehir cohort from cBioPortal was used to analyze the mutations (MT) frequency of NTRK family in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Xiaoling, Zhang, Wengang, Han, Wenfei, Xia, Handai, Liu, Ni, Wang, Xiuwen, Liu, Yanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688060/
https://www.ncbi.nlm.nih.gov/pubmed/38031067
http://dx.doi.org/10.1186/s12890-023-02707-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688060/
https://www.ncbi.nlm.nih.gov/pubmed/38031067
http://dx.doi.org/10.1186/s12890-023-02707-x

Ejemplares similares